E2F1 down-regulation promotes lipid droplet accumulation and endometriosis development through impaired MGLL-mediated lipid mobilization
E2F1 downregulation impairs MGLL-mediated lipid mobilization, promoting lipid droplet accumulation and endometriosis development through altered phospholipid and cholesterol levels in ectopic stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (72)
- Body mass index in endometriosis via openalex
- C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis via openalex
- Clinical practice. Endometriosis via openalex
- Correlation between lipid metabolism and endometriosis: a meta-analysis via openalex
- Diagnostic Value of Menstrual Blood Lipidomics in Endometriosis: A Pilot Study via openalex
- Discovery of Phosphatidic Acid, Phosphatidylcholine, and Phosphatidylserine as Biomarkers for Early Diagnosis of Endometriosis via openalex
- Elevated serum lipoprotein(a) levels in young women with endometriosis via openalex
- Emerging hallmarks of endometriosis metabolism: A promising target for the treatment of endometriosis via openalex
- Endometrial-peritoneal interactions during endometriotic lesion establishment via openalex
- Endometriosis is not the endometrium: Reviewing the over-representation of eutopic endometrium in endometriosis research via openalex
- Endometriosis: recent advances that could accelerate diagnosis and improve care via openalex
- Endometrium and endometriosis tissue mitochondrial energy metabolism in a nonhuman primate model via openalex
- ERβ-activated LINC01018 promotes endometriosis development by regulating the CDC25C/CDK1/CyclinB1 pathway via openalex
- Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator via openalex
- Integration analysis of microRNA and mRNA paired expression profiling identifies deregulated microRNA-transcription factor-gene regulatory networks in ovarian endometriosis via openalex
- Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro via openalex
- Knockdown of long noncoding RNA CCDC144NL-AS1 attenuates migration and invasion phenotypes in endometrial stromal cells from endometriosis† via openalex
- Metabolic reprogramming in endometriosis: mechanisms and therapeutic prospects via openalex
- Metabolomics in endometriosis: challenges and perspectives for future studies via openalex
- Nonhormonal therapy for endometriosis based on energy metabolism regulation via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review via openalex
- PrPC Promotes Endometriosis Progression by Reprogramming Cholesterol Metabolism and Estrogen Biosynthesis of Endometrial Stromal Cells through PPARα Pathway via openalex
- Relationship between triglyceride-glucose index and endometriosis: a cross-sectional analysis via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- Transforming growth factor-β induced Warburg-like metabolic reprogramming may underpin the development of peritoneal endometriosis via openalex
- Understanding the molecular mechanisms of macrophage polarization and metabolic reprogramming in endometriosis: A narrative review via openalex
- Warburg-like Metabolic Reprogramming in Endometriosis: From Molecular Mechanisms to Therapeutic Approaches via openalex
- W4380319688 via openalex
- W4386471647 via openalex
- W4388416895 via openalex
- W4391537439 via openalex
- W4394620630 via openalex
- W4394726364 via openalex
- W4399202410 via openalex
- W4400240889 via openalex
- W4406360596 via openalex
- W4412635745 via openalex
- W4412724882 via openalex
- W4415381438 via openalex
- W4416531306 via openalex
- W4417068348 via openalex
- W7124251422 via openalex
- W7133887257 via openalex
- W7168852211 via openalex
- W1706150252 via openalex
- W1975229775 via openalex
- W1980759602 via openalex
- W1984252723 via openalex
- W2063297728 via openalex
- W2065343028 via openalex
- W2121233961 via openalex
- W2127624416 via openalex
- W2163953252 via openalex
- W2178023527 via openalex
- W2185464160 via openalex
- W2280082157 via openalex
- W2609484747 via openalex
- W2740141750 via openalex
- W2768073235 via openalex
- W2809921982 via openalex
- W2903107073 via openalex
- W2980866465 via openalex
- W2988365714 via openalex
- W3134885188 via openalex
- W3137440484 via openalex
- W3161968936 via openalex
- W3165294846 via openalex
- W3203453680 via openalex
- W4376875205 via openalex
- W4379052379 via openalex
- W4379618280 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-11-13T07:00:47.251693+00:00
- openalex
- last seen: 2026-11-13T06:53:04.716285+00:00
- pubmed
- last seen: 2026-11-13T06:54:53.877619+00:00
Courtesy of the U.S. National Library of Medicine